Citigroup’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-37,887
| Closed | -$81.5K | – | 4831 |
|
|
2024
Q2 | $81.5K | Sell |
37,887
-32,920
| -46% | -$70.8K | ﹤0.01% | 3595 |
|
|
2024
Q1 | $230K | Sell |
70,807
-89,679
| -56% | -$291K | ﹤0.01% | 3214 |
|
|
2023
Q4 | $3.29M | Buy |
160,486
+1,381
| +0.9% | +$28.3K | ﹤0.01% | 1344 |
|
|
2023
Q3 | $2.56M | Buy |
159,105
+24,632
| +18% | +$396K | ﹤0.01% | 1346 |
|
|
2023
Q2 | $1.14M | Hold |
134,473
| – | – | ﹤0.01% | 2150 |
|
|
2023
Q1 | $1.33M | Sell |
134,473
-75
| -0.1% | -$740 | ﹤0.01% | 1818 |
|
|
2022
Q4 | $1.28M | Buy |
134,548
+3
| +0% | +$29 | ﹤0.01% | 1831 |
|
|
2022
Q3 | $2.34M | Buy |
134,545
+46,770
| +53% | +$813K | ﹤0.01% | 1506 |
|
|
2022
Q2 | $680K | Buy |
+87,775
| New | +$680K | ﹤0.01% | 2380 |
|